SMTL ID : 6haz.1

Crystal structure of the bromodomain of human SMARCA2 in complex with SMARCA-BD ligand

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.31 Å

Oligo State

homo-dimer

Ligands

2 x FX5: 2-(6-azanyl-5-piperazin-4-ium-1-yl-pyridazin-3-yl)phenol(Non-covalent)

FX5.1: 17 residues within 4Å: Chain A: V.38, F.39, Q.41, L.42, P.43, E.47, L.48, Y.51, V.59, D.60, L.86, N.89, A.90, F.93, N.94, I.100 Chain B: H.88 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.38, A:L.42 Hydrogen bonds: A:Y.51, A:N.94, A:N.94 pi-Stacking: A:F.39 FX5.3: 16 residues within 4Å: Chain B: V.38, F.39, Q.41, L.42, P.43, E.47, L.48, Y.51, V.59, D.60, L.86, N.89, A.90, F.93, N.94, I.100 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:L.42 Hydrogen bonds: B:Y.51, B:N.94, B:N.94 pi-Stacking: B:F.39

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 3 residues within 4Å: Chain A: P.43, E.47 Chain B: H.88 5 PLIP interactions: 1 interactions with chain B, 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: B:H.88, A:E.47, A:E.47, H2O.4, H2O.5 ZN.4: 2 residues within 4Å: Chain B: P.43, E.47 4 PLIP interactions: 2 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:E.47, B:E.47, H2O.11, H2O.12

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farnaby, W. et al., BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat.Chem.Biol. (2019)

Release Date

2019-06-12

Peptides

Probable global transcription activator SNF2L2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Probable global transcription activator SNF2L2

Related Entries With Identical Sequence